Actively Recruiting
Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches
Led by The University of Hong Kong · Updated on 2025-04-03
261
Participants Needed
4
Research Sites
131 weeks
Total Duration
On this page
Sponsors
T
The University of Hong Kong
Lead Sponsor
R
Research Grants Council, Hong Kong
Collaborating Sponsor
AI-Summary
What this Trial Is About
The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.
CONDITIONS
Official Title
Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (stage III or IV) cancer
- Age 18 years or older
You will not qualify if you...
- Patients with major communication difficulties
- Patients unwilling or unable to commit to 6 psychotherapy sessions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Queen Mary Hospital-Department of Obstetrics & Gynaecology
Hong Kong, Hong Kong
Actively Recruiting
2
Queen Mary Hospital-Department of Oncology
Hong Kong, Hong Kong
Not Yet Recruiting
3
Queen Mary Hospital-Department of Surgery
Hong Kong, Hong Kong
Actively Recruiting
4
Tung Wah Hospital-Department of Surgery
Hong Kong, Hong Kong
Not Yet Recruiting
Research Team
D
Danielle Wing Lam Ng, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here